Correct Answer: D. Splenectomy
Splenectomy is the definitive treatment for chronic ITP in patients who respond to steroids. The pathophysiology of ITP involves autoimmune destruction of platelets by IgG antibodies, with the spleen being the primary site of both antibody production and platelet destruction. In steroid-responsive patients (approximately 80% of adults), splenectomy achieves complete remission in 60–80% of cases because removal of the spleen eliminates the major organ responsible for platelet sequestration and destruction. The decision for splenectomy follows a stepwise approach: first-line steroids (prednisolone 1 mg/kg/day) are given for 4–6 weeks; if remission occurs, steroids are tapered. Patients who relapse during taper or require unacceptably high maintenance doses are candidates for splenectomy. The procedure is curative in steroid-responders because it removes the site of anti-platelet antibody production and the reticuloendothelial tissue that destroys antibody-coated platelets. Post-splenectomy, patients require vaccination against encapsulated organisms (pneumococcus, meningococcus, Haemophilus influenzae) and lifelong penicillin prophylaxis per Indian guidelines. Response to splenectomy is a strong predictor of response to other immunosuppressive agents, making it a logical second-line choice in the treatment algorithm.
Why the other options are wrong
A. Blood transfusion — Blood transfusion is contraindicated in ITP except in life-threatening hemorrhage. Transfused platelets are rapidly destroyed by the same autoimmune mechanism, making transfusion ineffective and wasteful of precious blood bank resources. In India, where blood availability is limited, transfusion is reserved only for active bleeding with platelet count <10,000/µL unresponsive to other measures. B. Steroids — While steroids are the first-line treatment for ITP, they are not the 'best' definitive treatment. Steroids induce remission in ~80% of acute cases but only 20–30% maintain remission after taper. Long-term steroid use causes significant morbidity (osteoporosis, infections, metabolic complications). Splenectomy offers durable remission in steroid-responders and is the next logical step, not steroids alone. C. IV immunoglobulins — IVIG is a temporizing measure, not definitive treatment. It works by blocking Fc receptors on macrophages, providing rapid platelet increment (within 24–48 hours) in acute bleeding or pre-operative situations. However, its effect is transient (1–4 weeks), making it unsuitable as sole long-term therapy. IVIG is used as bridge therapy before splenectomy or in steroid-refractory cases, not as primary definitive treatment.
High-Yield Facts
- Splenectomy response rate: 60–80% complete remission in steroid-responsive chronic ITP patients; response predicts sensitivity to other immunosuppressants.
- ITP pathophysiology: Autoimmune IgG antibodies destroy platelets; spleen is the primary site of both antibody production and platelet sequestration.
- First-line treatment: Prednisolone 1 mg/kg/day for 4–6 weeks; splenectomy is second-line after steroid response/relapse.
- Post-splenectomy prophylaxis: Mandatory vaccination (pneumococcus, meningococcus, H. influenzae) + lifelong penicillin V 250 mg BD per Indian guidelines.
- IVIG role: Rapid platelet increment (24–48 h) for acute bleeding or pre-operative bridging; transient effect (1–4 weeks), not definitive.
- Steroid-refractory ITP: ~20% of patients; managed with IVIG, rituximab, or other immunosuppressants; splenectomy less effective if steroid-resistant.
Mnemonics
ITP Treatment Ladder (SPICE) Steroids (first-line) → Platelet transfusion (emergency only) → IVIG (bridge) → Chemotherapy/rituximab (refractory) → Explore splenectomy (if steroid-responsive). Use this to remember the stepwise escalation and why splenectomy is not first-line but definitive in responders. Splenectomy Success: RESPOND Response to steroids (predictor of splenectomy success) → Eliminate spleen (site of destruction) → Steroid-dependent patients (best candidates) → Post-op prophylaxis (vaccines + penicillin) → Ongoing monitoring → No relapse in 60–80% → Durable remission. Helps recall why steroid-responders are ideal candidates.
NBE Trap
NBE may pair "ITP" with "IVIG" to lure students into choosing rapid platelet increment over durable remission. The trap is confusing acute management (IVIG for bleeding) with definitive treatment (splenectomy for cure). Similarly, "steroids" as first-line therapy may distract from the question asking for the "best" (most durable) treatment.
Clinical Pearl
In Indian practice, a steroid-responsive ITP patient who relapses during prednisolone taper or requires >20 mg/day maintenance is a prime candidate for splenectomy referral. Post-splenectomy, ensure vaccination before discharge and counsel on lifelong penicillin prophylaxis—a critical gap in many Indian centers that leads to overwhelming post-splenectomy infection (OPSI), a preventable cause of mortality.
_Reference: Robbins & Cotran Pathologic Basis of Disease, Ch. 13 (Hematologic Disorders); Harrison's Principles of Internal Medicine, Ch. 140 (Thrombocytopenia); KD Tripathi Essentials of Medical Pharmacology, Ch. 12 (Immunosuppressants)_